Hepatocellular Carcinoma (HCC) Treatment in Delhi, India

Hepatocellular carcinoma (HCC) is a type of liver cancer that starts in the primary cells of the liver, known as hepatocytes. Unlike cancers that spread to the liver from other parts of the body, HCC begins within the liver itself.

This condition often develops in people who have long-term liver problems, such as cirrhosis or chronic hepatitis infections. Over time, repeated liver damage can cause healthy cells to turn abnormal, eventually forming a tumour.

Hepatocellular carcinoma begins when liver cells (hepatocytes) undergo changes in their DNA. DNA acts as the instruction manual that controls how cells grow, function, and die. When these instructions are altered, the cells can multiply uncontrollably and form a tumour. Over time, the tumour may invade healthy tissue and, in advanced cases, spread to other parts of the body.

The most common causes that lead to these changes include:

• Cirrhosis (liver scarring) – long-term damage to the liver that increases the likelihood of abnormal cell growth.
• Hepatitis B or C infection – chronic viral infections that damage liver tissue over time.
• Chronic liver inflammation – often caused by alcohol use, fatty liver disease, or other liver conditions.
• Unclear or unknown causes – in some individuals, HCC may develop even without any known preexisting liver condition.

Hepatocellular carcinoma may not cause noticeable symptoms in its early stages, which is why regular monitoring is important for people at higher risk. When symptoms do appear, they may develop gradually and vary from person to person. Recognising these signs early can support timely diagnosis and treatment.

• Unexplained weight loss: a steady drop in weight without changes in diet or activity can signal an underlying problem.
• Loss of appetite or feeling full quickly: the tumour may affect how the liver processes food and digestion.
• Persistent tiredness or weakness: reduced liver function can make the body feel fatigued even after rest.
• Pain or discomfort in the upper right abdomen: as the liver enlarges, it can cause a dull ache or pressure under the ribs.
• Swelling in the abdomen (ascites): fluid build-up may occur when liver function is impaired.
• Jaundice (yellowing of the skin and eyes): a common sign of liver disease caused by the build-up of bilirubin in the blood.
• Nausea or vomiting: the liver’s reduced ability to process toxins can affect digestion and appetite.
• Itchy skin: a result of bile salt build-up in the bloodstream.
• Enlarged spleen: often linked with advanced liver disease and portal hypertension.

Many of these signs can also be caused by conditions other than liver cancer, which is why timely medical evaluation is essential. Detecting the disease early can make a significant difference in treatment options and outcomes.

At Max Hospitals, our doctors use advanced diagnostic methods to detect hepatocellular carcinoma early, determine its stage, and understand the liver’s condition, ensuring that each patient receives focused and personalised care. Common diagnostic methods include:

• Medical history and physical examination: The doctor reviews symptoms, checks for existing liver conditions, and examines the abdomen for swelling or tenderness.
• Blood tests: These tests measure liver function and detect tumour markers like alpha-fetoprotein (AFP), which can point to HCC.
• Imaging studies: Ultrasound, CT scans, and MRI help doctors spot abnormal growths and understand their size and location. Contrast MRI is often considered highly sensitive in detecting HCC.
• Liver biopsy: If needed, the doctor removes a small tissue sample from the liver to confirm the diagnosis.
• Staging tests: After confirming HCC, doctors run further tests to understand how far the cancer has spread and plan treatment accordingly.

Detecting HCC in its early stages can improve treatment outcomes and overall prognosis. That’s why regular screening and preventive health check-ups are vital, especially for those at increased risk, to spot changes in liver health before the disease progresses.

Every case of hepatocellular carcinoma (HCC) is different, and that’s why at Max Hospitals, our team of hepatologists, surgeons, interventional radiologists, medical oncologists, and radiation physicians works closely with patients and their families to create personalised treatment strategies. The choice of treatment depends on several factors, including the stage of the disease, liver function, overall health, and patient preferences. This multidisciplinary approach allows us to design a plan that not only targets the disease but also focuses on preserving liver function and improving quality of life.

• Surgery or Transplantation: For patients with early-stage disease and good liver function, surgery may offer the best chance of long-term control or cure. A hepatectomy involves removing the tumour along with a portion of the healthy liver. Because the liver can regenerate, this procedure can be highly effective when the cancer is localised. In some cases, a liver transplant may be a better option, particularly when the underlying liver is damaged by cirrhosis. A transplant replaces the diseased liver with a healthy donor liver, treating both the tumour and the underlying liver disease. Patients are carefully assessed before surgery or transplantation to ensure the best possible outcomes.
• Targeted Therapies: When surgery isn’t suitable, loco-regional targeted treatments can help kill the tumour directly. Ablation therapies, such as radiofrequency ablation (RFA) and microwave ablation (MWA) use heat energy to destroy cancer cells. These procedures are minimally invasive and often used for smaller tumours. Another approach, called tumor embolization (TACE) cuts off the tumour’s blood supply by delivering chemotherapy and occlusive particles directly to it. A more advanced targeted approach is Radio embolization (TARE) which delivers a fine particles of radioactive material (Yttrium 90) directly to the tumor to kill it from inside out. These targeted therapies are particularly useful for controlling disease progression, but can also serve as a bridge to liver transplantation or as a down staging modality to liver transplant for those outside transplant criteria.
• Systemic Treatments: For advanced stages of hepatocellular carcinoma or when local treatments are not possible, systemic therapy can help slow disease progression and relieve symptoms. Systemic therapies work by blocking specific pathways that allow cancer cells to grow, while immunotherapy helps the body’s immune system recognise and attack these cells. These treatments are carefully monitored by specialists to manage side effects and adjust the approach as needed.
• Radiation Therapy: In selected cases, radiation therapy is used to shrink tumours or control symptoms. Modern techniques such as stereotactic body radiotherapy (SBRT) deliver high doses of radiation precisely to the tumour while sparing healthy liver tissue. This can help manage pain or reduce the tumour burden in patients who are not candidates for surgery or ablation.
• Supportive and Palliative Care: Beyond treating the tumour, managing symptoms is a crucial part of care. Supportive care focuses on improving comfort and quality of life by addressing pain, fatigue, nutrition, and emotional well-being. In advanced cases, palliative care helps patients and their families maintain dignity and comfort throughout the treatment journey.
• Follow-Up and Monitoring: Regular follow-up after treatment is essential to detect any recurrence early and to monitor liver health. Follow-up typically includes clinical assessments, blood tests such as AFP levels, and imaging studies at scheduled intervals. Patients are also encouraged to adopt healthy lifestyle habits, such as avoiding alcohol, maintaining a balanced weight, and managing underlying liver conditions, to support recovery and long-term outcomes.

While not everyone with liver damage develops hepatocellular carcinoma, certain factors can increase the overall risk. Recognizing these factors can help with early detection and timely intervention.

Common risk factors include:

• Hepatitis B or C infection: These viral infections can cause ongoing inflammation in the liver, leading to scarring and DNA damage that may trigger cancerous growth.
• Cirrhosis: This condition involves irreversible scarring of liver tissue, creating an environment in which cancer cells are more likely to develop.
• Inherited liver diseases: Conditions like haemochromatosis and Wilson’s disease can cause iron or copper build-up in the liver, leading to chronic damage and a higher cancer risk.
• Metabolic dysfunction-associated steatotic liver disease (MASLD): Excess fat stored in liver cells can cause inflammation and scarring, which may eventually progress to cancer if not managed.
• Diabetes: High blood sugar levels can strain the liver and contribute to conditions like fatty liver disease, indirectly increasing the risk of HCC.
• Obesity: Excess body weight is strongly linked to liver fat accumulation, which can lead to cirrhosis and raise the risk of cancer over time.
• Aflatoxin exposure: Long-term consumption of mould-contaminated foods, such as grains and nuts, exposes the liver to toxins that can cause DNA mutations.
• Long-term alcohol consumption: Continuous heavy drinking can lead to inflammation, cirrhosis, and eventually liver cancer.
• Cigarette smoking: Chemicals in tobacco can damage liver cells directly or worsen the effects of other liver conditions, compounding the risk of HCC.
• Older age: The chances of developing liver cancer rise with age, as prolonged exposure to liver damage or chronic conditions increases over time. 

Understanding both the causes and risk factors of HCC plays a crucial role in prevention, early diagnosis, and improving treatment outcomes.

Hepatocellular carcinoma (HCC) can give rise to several complications, especially when detected at an advanced stage or left untreated. These may affect both liver function and overall health. Common complications include:

• Liver failure: As the tumour damages healthy liver tissue, the liver may lose its ability to perform vital functions.
• Tumour rupture: A growing tumour can sometimes rupture, leading to sudden abdominal pain and internal bleeding.
• Internal bleeding: Invasion of nearby blood vessels increases the risk of bleeding, which can be life-threatening.
• Metastasis: Cancer cells can spread to other parts of the body, such as the lungs or bones, making treatment more complex.
• Ascites: Fluid buildup in the abdomen can cause discomfort, swelling, and breathing difficulties.
• Jaundice: Impaired liver function can lead to yellowing of the skin and eyes.
• Infections: Advanced liver disease may weaken the immune response, increasing the risk of infections.

Timely diagnosis, appropriate treatment, and regular monitoring can help reduce the risk of these complications and improve outcomes.

While not all cases of HCC can be prevented, many risk factors can be managed effectively through proactive care. Key preventive measures include:

• Prevent hepatitis B and C infections: Vaccination against hepatitis B offers strong protection against one of the leading causes of liver cancer. For hepatitis C, regular screening and timely treatment can help prevent long-term liver damage and lower cancer risk.
• Limit alcohol intake: Reducing or avoiding alcohol helps protect liver cells and decreases the likelihood of cirrhosis.
• Avoid smoking: Quitting smoking or avoiding tobacco altogether reduces the risk of developing liver cancer.
• Maintain a healthy weight: A balanced diet and regular physical activity can help prevent fatty liver disease and related complications.
• Control underlying conditions: Proper management of diabetes and other chronic liver diseases is essential to reduce additional strain on the liver.
• Store food safely: Keeping grains and nuts dry and properly stored prevents exposure to aflatoxins, harmful toxins that can increase cancer risk.
• Go for regular screening: Individuals with cirrhosis or chronic liver disease should undergo periodic check-ups and imaging tests to detect any early signs of cancer.

These steps, combined with a healthy lifestyle and regular medical supervision, can significantly lower the risk of developing hepatocellular carcinoma.

1. Is hepatocellular carcinoma the same as liver cancer?

Hepatocellular carcinoma (HCC) is the most common primary liver cancer, meaning it starts in the liver itself. Other types of liver cancer exist, but HCC accounts for the majority of cases worldwide.

2. Can hepatocellular carcinoma occur without liver disease?

Yes, although most people with HCC have underlying liver conditions like hepatitis or cirrhosis, some develop the disease without any known risk factors. In such cases, genetic mutations or environmental factors may play a role.

3. How fast does hepatocellular carcinoma grow?

The growth rate varies from person to person. Some tumours grow slowly over months or years, while others progress more rapidly. Regular monitoring helps track any changes and guide treatment decisions.

4. Is hepatocellular carcinoma curable?

HCC can be cured if detected early and treated appropriately. Options like surgical resection, liver transplant, or loco regional therapies offer a good chance of long-term survival in early-stage disease. Advanced cases can still be managed to control symptoms and slow progression.

5. Who should get screened for hepatocellular carcinoma?

People with chronic liver disease, hepatitis B or C infection, cirrhosis, or other high-risk factors should undergo regular screening. Early detection greatly improves treatment outcomes.

6. How often should screening be done?

For high-risk individuals, screening is typically recommended every 6 months. This may involve imaging tests like ultrasound and blood tests such as AFP levels.

7. Can lifestyle changes reduce the risk of HCC?

Yes, maintaining a healthy weight, avoiding excessive alcohol, not smoking, getting vaccinated against hepatitis B, and managing underlying conditions can significantly lower the risk.

8. What is the survival rate for hepatocellular carcinoma?

Survival depends on the stage at which the cancer is diagnosed, liver function, and overall health. Early-stage cancers have much better outcomes compared to advanced disease.

9. Does HCC always cause symptoms in the early stage?

No, HCC often develops silently, with little or no symptoms initially. This is why regular check-ups and screening are so important for high-risk patients.

10. Can HCC return after treatment?

Yes, recurrence can occur, which is why regular follow-up visits, imaging tests, and blood work are essential even after successful treatment.

11. Is a liver transplant always required for HCC?

Not always. A transplant is an option in certain cases, especially when cirrhosis is present. Many patients may benefit from other treatments like surgery, ablation, embolisation, or systemic therapy.

12. How is HCC different from liver metastases?

HCC starts in the liver, whereas liver metastases originate in another part of the body and spread to the liver. The treatment and prognosis differ for both.

13. Are there any targeted therapies for HCC?

Yes, modern targeted drugs and immunotherapies are available for advanced stages. These treatments focus on blocking specific pathways that cancer cells use to grow and spread.

14. Can diet and nutrition impact liver cancer treatment?

Yes, a balanced diet helps support liver function and overall well-being during and after treatment. Patients are often advised to limit processed foods, avoid alcohol, and maintain a healthy weight.

15. How is pain managed in HCC patients?

Pain can be managed through medication, minimally invasive procedures, or radiation therapy if needed. Supportive care focuses on ensuring the patient’s comfort and quality of life.

16. Does family history increase the risk of HCC?

A family history of liver disease or liver cancer can increase risk, particularly if genetic liver disorders are involved. Genetic counselling may be advised in some cases.

17. Can people with HCC continue to work or live normally during treatment?

This depends on the stage of the disease, type of treatment, and overall health. Many patients can continue daily activities with proper support and adjustments.

18. How is treatment for HCC different in people with cirrhosis?

In patients with cirrhosis, the liver’s reserve function is lower, so treatment plans are tailored carefully to avoid further damage while controlling the tumour.

19. Are clinical trials available for HCC patients?

Yes, many clinical trials are underway globally to evaluate new drugs, therapies, and treatment combinations. Eligible patients may consider participating for access to advanced options.

20. Why is follow-up care important after HCC treatment?

Follow-up care helps detect recurrence early, monitor liver function, and address any long-term side effects. Regular appointments play a key role in improving survival and quality of life.

Reviewed by Dr. Shahnawaz B. Kaloo, Principal Consultant - Interventional Radiology, on 17 December 2025.